Insanity Labs

Science

Precision begins with rigorous measurement—bridging neuroimaging research, clinical validation, and deployable software.

From subtle signals to clinical clarity

Neuropsychiatric conditions often progress quietly. Our R&D focuses on detecting early, objective markers that traditional assessments miss—then translating those findings into tools clinicians can trust.

01 · Mayamind®

Dementia subtyping

Targets where diagnostic ambiguity is highest—supporting earlier, more specific subtype insight.

02 · Nimixa™

Cognitive task performance

Objective, technician-administered measurement of cognitive task performance—research use only in India.

03 · Clinical studies

Validation at scale

Research collaboration across geographies, with a path toward regulated medical use.

How we work

A clear path from clinical question to clinic-ready software—built with evidence and regulation in mind.

  1. 01

    Step 1

    Discover

    Partner with clinicians and researchers to identify high-value diagnostic gaps.

  2. 02

    Step 2

    Measure

    Design protocols that capture robust, repeatable digital biomarkers.

  3. 03

    Step 3

    Validate

    Test against clinical endpoints and real-world care workflows.

  4. 04

    Step 4

    Deploy

    Ship clinic-ready software with regulatory and operational realities in mind.